SEC Explores AI
The SEC considers using AI to create a fairer market by flagging corporate disclosure omissions and inconsistencies
The Securities and Exchange Commission is exploring the use of artificial intelligence to create a fairer market, as outlined in a recent article on regulation opportunities. This move comes as the agency seeks to increase the likelihood of detecting misconduct and changing the incentives that drive market abuse. By leveraging AI tools, the SEC can investigate corporate disclosures, flagging omissions, inconsistencies, or subtle shifts in tone that may indicate fraudulent activity. This is particularly relevant in light of recent cases, such as the Sportradar securities fraud class action, which resulted in a 22% stock decline.
The use of AI in regulatory oversight is not limited to the SEC, as other agencies have also begun to explore its potential. For example, a task force crackdown on Medicare fraud has led to a surge in claims, with Medicare claims for skin substitutes increasing by 7,100% from $200 million to $14.4 billion between 2019 and 2025, as reported on foxnews.com. This crackdown has sparked fraud probes and highlights the need for more effective regulatory tools. In another case, a California man was sentenced to 78 months in prison for a $39 million bank fraud scheme, demonstrating the severity of the issue. As regulators continue to grapple with these challenges, they may draw on lessons from other areas, such as the Paramount merger challenged or the Market manipulation probed.
The SEC's exploration of AI is part of a broader effort to modernize regulatory oversight and expand access to public markets. This includes hosting virtual roundtables and forming new working groups, such as the Retail Fraud Working Group, as announced on BizToc. As the agency moves forward with these initiatives, it will be important to monitor their impact on the market and ensure that they are effective in preventing fraud and manipulation. In related news, the FTC targets deceptive labels, highlighting the need for regulatory agencies to stay vigilant in their oversight of corporate activity. With big corporate sponsors in short supply, companies like Sanofi are stepping up to fill the gap, as reported in The Boston Globe's New England Finance & Business News.
Cross-reference independently — do not take our word for it.
Disclosure: NewsAnarchist uses AI-assisted reporting with web search. Always verify primary sources linked above.
This article is produced by NewsAnarchist's AI reporting system, not a human staff reporter. It's built from the primary source cited above (a company's own disclosure, a security researcher's published findings, a regulator's filing (FTC, EU data-protection authorities), or a data-breach notification) and reports what that source states, attributed to it — it is not security advice specific to your own devices or accounts, and does not verify a vendor's disputed claim beyond what the source states. Part of our Tech & Privacy hub. Found an error? Tell us.